Crispr Therapeutics shares owned by Merlin Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Merlin Capital
from 13F filings
Historical chart of Merlin Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Merlin Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Merlin Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $605k | 8.9k | 68.16 |
| 2023-12-31 | $559k | 8.9k | 62.60 |
| 2023-09-30 | $413k | 9.1k | 45.39 |
| 2023-06-30 | $494k | 8.8k | 56.14 |
| 2023-03-31 | $330k | 7.3k | 45.23 |
| 2022-12-31 | $277k | 6.8k | 40.65 |
| 2022-09-30 | $396k | 6.1k | 65.40 |